Senescence, apoptosis, and cancer
The Molecular Basis of Human Cancer, Page: 183-196
2016
- 1Citations
- 17Usage
- 8Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations1
- Citation Indexes1
- CrossRef1
- Usage17
- Abstract Views17
- Captures8
- Readers8
Book Chapter Description
Cancer cured in mice! Sounds hilarious to a nonacademic naive public, but for cancer researchers, every bit of information about cancer from worms, flies, and mice to human is immensely valuable. For a cancer biologist, it is not important to know in which living species on earth the cancer was cured, but how it was cured. We have learned a lot about the intricacy of signaling molecules and the underlying mechanisms involved in oncogenesis and cancer treatment. In this chapter, we review two important cellular properties, which are lost during cancer progression. These two properties, namely senescence and apoptosis, act as strong natural barriers to cancer. Vast majority of literature suggest that chemotherapeutics stop cancer progression by inducing apoptosis or cell death. In addition, the current literature also suggests that restoration of senescence in cancer cells by chemotherapeutic agents results in inhibition of cancer progression and in some cases even tumor regression.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85017851218&origin=inward; http://dx.doi.org/10.1007/978-1-59745-458-2_10; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85018861333&origin=inward; http://link.springer.com/10.1007/978-1-59745-458-2_10; https://hsrc.himmelfarb.gwu.edu/smhs_biochem_facpubs/244; https://hsrc.himmelfarb.gwu.edu/cgi/viewcontent.cgi?article=1246&context=smhs_biochem_facpubs; https://dx.doi.org/10.1007/978-1-59745-458-2_10; https://link.springer.com/chapter/10.1007/978-1-59745-458-2_10
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know